Abigail Stanton
Psychiatry · Glendale, CANPI 1518928589
Payments from drug & device makers
Across 359 payments — averaging $19.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- AbbVie$902
- Sunovion Pharmaceuticals Inc.$855
- Otsuka America Pharmaceutical, Inc.$788
- Lundbeck LLC$775
- Alkermes, Inc.$629
- plus $2K from 14 others
What the payments were for
- Food & beverage$7,145100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 59 | $1,216 |
| AbbVie(2 entities) | 54 | $902 |
| Sunovion Pharmaceuticals Inc. | 51 | $855 |
| Otsuka America Pharmaceutical, Inc. | 30 | $788 |
| Lundbeck LLC | 42 | $775 |
| Alkermes, Inc. | 32 | $629 |
| Takeda Pharmaceuticals U.S.A., Inc. | 30 | $551 |
| Neurocrine Biosciences, Inc. | 7 | $316 |
| Vanda Pharmaceuticals Inc. | 9 | $245 |
| Teva Pharmaceuticals USA, Inc. | 12 | $181 |
| Indivior Inc. | 7 | $165 |
| Avanir Pharmaceuticals, Inc. | 7 | $153 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $96 |
| Bausch Health US, LLC | 4 | $61 |
| Idorsia Pharmaceuticals US Inc | 3 | $59 |
| Axsome Therapeutics, Inc. | 2 | $58 |
| Ironshore Pharmaceuticals Inc. | 2 | $38 |
| Adlon Therapeutics L.p. | 2 | $25 |
| Merck | 1 | $18 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ABILIFY MAINTENA$242
- SPRAVATO$125
- INGREZZA$119
How this compares
$7,145 in reported general payments places this provider in the 90th percentile of 4,954 psychiatry providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 54 | $4,062 |
| Paliperidone ErPaliperidone | 11 | $4,062 |
| Bupropion XlBupropion Hcl | 103 | $4,002 |
| Quetiapine Fumarate | 49 | $2,253 |
| Duloxetine Hcl | 29 | $1,849 |
| Lamotrigine | 96 | $1,304 |
| Fluvoxamine Maleate | 30 | $1,262 |
| Olanzapine | 12 | $1,154 |
| Methylphenidate Hcl | 31 | $1,046 |
| Clonazepam | 129 | $1,017 |
| Escitalopram Oxalate | 51 | $975 |
| Sertraline Hcl | 93 | $783 |
| Divalproex Sodium ErDivalproex Sodium | 25 | $708 |
| Fluoxetine Hcl | 44 | $679 |
| Paroxetine Hcl | 15 | $589 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Glendale
- Brock SummersGlendale$2.1M
- Elly LeeIrvine$49.8M
- Daniel ChuehOrange$17.9M
- Eric ChavezSan Diego$15.5M
- Lara ShirikjianTorrance$12.6M
- John DuffySanta Ana$12M
- Marina BusselPlaya Vista$12M
- Sherry SoefjeOceanside$11.9M
- Steven MacinaHuntington Beach$11.1M
- Wakelin McNeelRosemead$11M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.